STXBP5 and breast carcinoma: For instance, Rh2 demonstrates therapeutic potential in breast cancer by intricately regulating lncRNAs such as STXBP5-AS1 [18] and CFAP20DC-AS1 (formerly known as C3orf67-AS1) [19].